1 Introduction Diabetic kidney disease (DKD) is a major diabetes-related microvascular disorder and currently accounts for a substantial proportion of end-stage renal disease (ESRD) worldwide [1, 2]. Approximately 40% of individuals with diabetes progress to ESRD [3], imposing a substantial economic burden worldwide. DKD pathogenesis is intricate and variable; accordingly, new DKD treatments are urgently required.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Beibei
Contact Beibei, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack